TITLE

Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia

AUTHOR(S)
Jachmann-Jahn, U.; Cornely, O. A.; Laufs, U.; Höpp, H. W.; Meuthen, I.; Krakau, M.; O'Brien, B.; Höpp, H W
PUB. DATE
November 2001
SOURCE
Annals of Hematology;Nov2001, Vol. 80 Issue 11, p677
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
A 42-year-old man was admitted with heavy retrosternal pain lasting 30 min. Electrocardiography showed typical signs of acute anterior myocardial infarction. The patient reported only attacks of coughing for a couple of days, and no serious diseases. The physical examination was normal. Laboratory tests showed a white blood cell count of 45/nl, platelet count of 58/nl, and hemoglobin of 14.4 g/dl. Blood chemistry showed elevated lactic dehydrogenase (413 U/l) but no elevation in creatine phosphokinase or glutamic-oxaloacetic transaminase. Therefore no thrombolysis was administered, but coronary angiography was performed. This showed a long-distance, subtotal thrombotic occlusion of the left anterior descending artery. After percutaneous transluminal coronary angioplasty and implantation of serial stents a normal perfusion of the artery was observed. The patient's blood and bone marrow films revealed acute myeloid leukemia FAB M2. Various conditions can cause a myocardial infarction in leukemias. We discuss the clinical management and the possible reasons for a subtotal thrombotic occlusion of the coronary artery.
ACCESSION #
15684816

 

Related Articles

  • Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Ohnishi, K.; Yoshida, H. // Leukemia (08876924);Apr2002, Vol. 16 Issue 4, p617 

    Studies arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia. Need for careful electrocardiogram monitoring; Analysis of pertinent topics and relevant issues; Implications on the study of leukemia.

  • ECG of the month. Regan, Clare; Regan, Martin // British Journal of Cardiac Nursing;Jun2014, Vol. 9 Issue 6, p267 

    The article presents the electrocardiogram of a 59-year-old man who was presented to the critical care unit following primary percutaneous coronary intervention for myocardial infarction and asks cardiac care nurses to analyze it.

  • Hyperacute stent thrombosis after pre-hospital assessment for primary angioplasty (PAPA) ST elevation myocardial infarction. Femia, G.; Fetahovik, T.; Tiberio, T.; Yeung, A.; Lee, A. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS277 

    No abstract available.

  • Country cardiograms case 52. Toman, Inka; McGrath, Brent M. // Canadian Journal of Rural Medicine;Fall2014, Vol. 19 Issue 4, p151 

    The article describes the case of a 46 year old man presented to the emergency department with acute-onset retrosternal chest pain the patient described as feeling like a rock on his chest. The patient reported a feeling of faintness and excessive sweating and his only relevant medical history...

  • Women Face Higher Bleeding Risk After Receiving Coronary Stents.  // Heart Advisor;Apr2012, Vol. 15 Issue 4, p7 

    The article reports on a study which shows that women patients treated with emergency stenting for heart attack had significantly higher rates of bleeding than men.

  • The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores. Căzăceanu, O.; Vlădăreanu, A. M.; Bumbea, H.; Begu, M.; Onisai, M.; Enache, C. // Journal of Medicine & Life;Jul-Sep2014, Vol. 7 Issue 3, p335 

    Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders; they are characterized by ineffective hematopoiesis and a predilection to the development of acute myeloid leukemia (AML). For a rapid evaluation of the outcome in myelodysplastic patients...

  • Influence of Prognostic Factors on Overall Survival in Myelodysplastic Syndromes. Sotirova, Tatjana; Stojanovic, Aleksandar; Genadieva-Stavric, Sonja; Krstevska, Svetlana; Spasovski, Dejan; Balkanov, Trajan // Materia Socio Medica;Oct2014, Vol. 26 Issue 5, p292 

    Background: Accurate prediction of a patient's prognosis is useful to define the risk posed by the disease. Age, gender, peripheral blood cytopenia, proportion of bone marrow (BM) blasts, performance status, comorbidities, transfusion dependence, specific karyotype abnormalities and molecular...

  • FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Yoshimoto, G.; Nagafuji, K.; Miyamoto, T.; Kinukawa, N.; Takase, K.; Eto, T.; Kato, K.; Hayashi, S.; Kamimura, T.; Ohno, Y.; Taniguchi, S.; Harada, M. // Bone Marrow Transplantation;Dec2005, Vol. 36 Issue 11, p977 

    Summary:We retrospectively analysed the significance of FLT3 mutations in patients with acute myeloid leukemia (AML) having a normal karyotype, who were treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation (auto-PBSCT). In all, 34 patients with normal...

  • The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia. Chou, W.-C.; Lei, W.-C.; Ko, B.-S.; Hou, H.-A.; Chen, C.-Y.; Tang, J.-L.; Yao, M.; Tsay, W.; Wu, S.-J.; Huang, S.-Y.; Hsu, S.-C.; Chen, Y.-C.; Chang, Y.-C.; Kuo, K.-T.; Lee, F.-Y.; Liu, M.-C.; Liu, C.-W.; Tseng, M.-H.; Huang, C.-F.; Tien, H.-F. // Leukemia (08876924);Feb2011, Vol. 25 Issue 2, p246 

    Although the clinical features of the Isocitrate dehydrogenase 2 (IDH2) mutation in acute myeloid leukemia (AML) have been characterized, its prognostic significance remains controversial and its stability has not been investigated. We analyzed 446 adults with primary non-M3 AML and found IDH2...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics